Murlentamab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5694
Add to Compare
$710.00 - $6,900.00
Delivery Time : 4 weeks

Murlentamab Biosimilar - Research Grade

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
AMHR2ï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
Q16671
Shipping Conditions
Blue ice
Background
Anti-Mullerian hormone receptor type 2 (AMHR2) transmits AMH signaling and shapes gonadal and reproductive development, with emerging relevance to gynecologic and immuno-oncology research. This recombinant human IgG1 kappa antibody is an unconjugated, non-therapeutic analog of murlentamab raised against AMHR2 and offered for research use only (RUO). Because it is formulated to a low-endotoxin standard, it is suitable for in vivo use, and it is produced in scalable milligram (mg) to gram (g) quantities to support heavy-usage and high-throughput laboratories. It functions in receptor-binding functional assays, in vitro screening, ADCC studies, and preclinical disease models.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review
You're reviewing:Murlentamab Biosimilar - Research Grade
Your Rating
Back to Top